Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry
Thrombosis and Haemostasis · 01.11.2023 · 123 (11) · 1089-1099
DOI: 10.1055/a-2087-3003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.11.2023. Verfasst von Dimitrios Giannis und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Systems Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States. Hauptthemen laut MEDLINE: Venous Thromboembolism, COVID-19, Pulmonary Embolism, Heart Failure. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, Broxmeyer Fellowship in Clinical Thrombosis and Janssen Pharmaceuticals, National Institute on Aging.
Abstract (Originalsprache)
Background
Coronavirus disease 2019 (COVID-19) is associated with venous and arterial thromboembolism (VTE and ATE) and all-cause mortality (ACM) in hospitalized patients. High-quality data are needed on postdischarge outcomes in patients with cardiovascular disease.
Objectives
To analyze outcomes and identify risk factors for ATE, VTE, and ACM in a high-risk subgroup of hospitalized COVID-19 patients with baseline cardiovascular disease.
Methods
We investigated postdischarge rates and associated risk factors of ATE, VTE, and ACM in 608 hospitalized COVID-19 patients with coronary artery disease, carotid artery stenosis (CAS), peripheral arterial disease (PAD), or ischemic stroke.
Results
Through 90 days postdischarge, outcome rates were: ATE 27.3% (10.2% myocardial infarction, 10.1% ischemic stroke, 13.2% systemic embolism, 12.7% major adverse limb event); VTE 6.9% (4.1% deep vein thrombosis, 3.6% pulmonary embolism); composite of ATE, VTE, or ACM 35.2% (214/608). Multivariate analysis showed significant association between this composite endpoint and age >75 years (odds ratio [OR]: 1.90, 95% confidence interval [CI]: 1.22–2.94, p = 0.004), PAD (OR: 3.23, 95% CI: 1.80–5.81, p ≤ 0.0001), CAS (OR: 1.74, 95% CI: 1.11–2.75, p = 0.017), congestive heart failure (CHF) (OR: 1.84, 95% CI: 1.02–3.35, p = 0.044), previous VTE (OR: 3.08, 95% CI: 1.75–5.42, p < 0.0001), and intensive care unit (ICU) admission (OR: 2.93, 95% CI: 1.81–4.75, p < 0.0001).
Conclusion
COVID-19 inpatients with cardiovascular disease experience high rates of ATE, VTE, or ACM through 90 days postdischarge. Age >75 years, PAD, CAS, CHF, previous VTE, and ICU admission are independent risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Health Systems Science, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, New York, United States.
- Department of Vascular Surgery, University of Thessaly, Larissa, Greece.
- Department of Medicine, Anticoagulation and Clinical Thrombosis Services, Northwell Health at Lenox Hill Hospital, New York, New York, United States.
- Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
- Department of Anesthesiology, University of Thessaly, Larissa, Greece.
ORCID-Profile: Alex C Spyropoulos
Förderung
- NIA NIH HHS
- Broxmeyer Fellowship in Clinical Thrombosis and Janssen Pharmaceuticals
- National Institute on Aging
- Hellenic Medical Society of New York
Zitieren
APA
Giannis, D., Goldin, M., Rahman, H., Sison, C. P., Lesser, M. L., Ngu, S., Tsang, J., Qiu, M., Sanghani, S., Yeh, J., Matsagkas, M., Arnaoutoglou, E., & Spyropoulos, A. C. (2023). Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry. Thrombosis and Haemostasis, 123(11), 1089-1099. https://doi.org/10.1055/a-2087-3003
Vancouver
Giannis D, Goldin M, Rahman H, Sison CP, Lesser ML, Ngu S, et al. Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry. Thrombosis and Haemostasis. 2023;123(11):1089-1099. doi:10.1055/a-2087-3003
BibTeX
@article{Giannis2023,
author = {Giannis, Dimitrios and Goldin, Mark and Rahman, Husneara and Sison, Cristina P and Lesser, Martin L and Ngu, Sam and Tsang, James and Qiu, Michael and Sanghani, Shreya and Yeh, Jackson and Matsagkas, Miltiadis and Arnaoutoglou, Eleni and Spyropoulos, Alex C},
title = {Risk Factors for Postdischarge Major Thromboembolism and Mortality in Hospitalized Patients with COVID-19 with Cardiovascular Comorbidities: Insights from the CORE-19 Registry},
journal = {Thrombosis and Haemostasis},
year = {2023},
volume = {123},
number = {11},
pages = {1089--1099},
doi = {10.1055/a-2087-3003}
}
EUVIMED